Galaxy Surfactants Q4FY26 Revenue Up 14.1%, PAT Declines
Galaxy Surfactants reported a 14.1% YoY increase in Q4FY26 revenue to ₹1,315.0 crore, while PAT fell 17.7% to ₹62.4 crore due to margin pressures from supply chain disruptions and rising feedstock costs. For the full year FY26, revenue grew 24.0% to ₹5,270.4 crore, with EBITDA declining 2.5% to ₹497.4 crore. The board recommended a final dividend of ₹22 per share. Management noted strong volume growth in India and the Americas, but challenges in the AMET region, and provided guidance for Q1 FY27 targeting the higher end of 6-8% volume growth.

*this image is generated using AI for illustrative purposes only.
Galaxy Surfactants Limited has announced its audited financial results for the quarter and full year ended March 31, 2026, alongside the recommendation of a final dividend. The company has also filed the transcript of its earnings conference call held on May 15, 2026, to discuss the operational and financial performance for Q4 and FY26.
Consolidated total revenue stood at ₹1,315.0 crore in Q4FY26, marking a 14.1% year-on-year (YoY) increase, while full-year FY26 revenue stood at ₹5,270.4 crore, up 24.0% YoY. However, profitability came under pressure, with Q4FY26 PAT declining 17.7% YoY to ₹62.4 crore amid a disrupted operating environment.
Consolidated Financial Performance
The company's consolidated results reflect resilient top-line growth alongside margin compression during the period. The following table summarises the key financial metrics:
| Particulars (₹ in Crores): | Q4FY26 | Q4FY25 | Y-o-Y | Q3FY26 | Q-o-Q | FY26 | FY25 | Y-o-Y |
|---|---|---|---|---|---|---|---|---|
| Total Revenue: | 1,315.0 | 1,152.7 | 14.1% | 1,334.3 | -1.4% | 5,270.4 | 4,249.5 | 24.0% |
| EBITDA: | 121.9 | 134.7 | -9.5% | 124.2 | -1.8% | 497.4 | 510.0 | -2.5% |
| EBITDA Margin: | 9.3% | 11.7% | — | 9.3% | — | 9.4% | 12.0% | — |
| PAT: | 62.4 | 75.9 | -17.7% | 59.0# | 5.9% | 267.4# | 304.9 | -12.3% |
| PAT Margin: | 1.4% | 2.1% | — | 1.1% | — | 1.2% | 1.8% | — |
| EPS (₹)*: | 17.60 | 21.40 | — | 16.63 | — | 75.41 | 86.00 | — |
*Not Annualised | #Includes ₹11.9 crore towards the statutory impact of the new labour codes
EBITDA for Q4FY26 stood at ₹121.9 crore, down 9.5% YoY from ₹134.7 crore in Q4FY25, with EBITDA per metric tonne at ₹20,113 versus ₹21,715 in the corresponding period. For the full year, EBITDA declined 2.5% to ₹497.4 crore from ₹510.0 crore in FY25, with EBITDA/MT at ₹19,357/MT versus ₹19,862/MT in FY25, and EBITDA margin contracting to 9.4% from 12.0%.
Operational Performance and Outlook
Management attributed the margin pressure to external disruptions, including geopolitical tensions in West Asia, which impacted global supply chains and feedstock prices. India volumes grew 8% YoY, driven by a 3% growth in performance and over 27% growth in specialty volumes. In contrast, the AMET region saw volumes decline 15% YoY due to logistical disruptions and raw material availability constraints. The Americas emerged as a bright spot with improved demand momentum following tariff reversals.
Looking ahead, the company indicated that for Q1 FY27, it expects to deliver volume growth at the higher end of the 6% to 8% range and EBITDA per metric tonne at the higher end of the ₹19,000 to ₹21,000 band, assuming the current scenario persists.
Dividend
The board has recommended a final dividend of ₹22 per share for the period under review.
| Dividend Details: | Amount |
|---|---|
| Final Dividend Per Share: | ₹22 |
Historical Stock Returns for Galaxy Surfactants
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.51% | -1.67% | -0.97% | -11.20% | -20.21% | -41.28% |
How long could geopolitical tensions in West Asia continue to weigh on Galaxy Surfactants' AMET region volumes, and what contingency sourcing strategies is the company exploring to mitigate raw material constraints?
Given the significant contraction in EBITDA margins from 12.0% in FY25 to 9.4% in FY26, what structural changes or pricing actions could the company implement to restore margins toward historical levels in FY27?
With the Americas showing improved demand momentum following tariff reversals, how significant could this region become as a revenue contributor, and is the company considering capacity expansion there?


































